These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 8142468)
41. Structure of the gene coding for the alpha polypeptide chain of the human complement component C4b-binding protein. Rodriguez de Cordoba S; Sanchez-Corral P; Rey-Campos J J Exp Med; 1991 May; 173(5):1073-82. PubMed ID: 2022920 [TBL] [Abstract][Full Text] [Related]
42. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Sandrin MS; Vaughan HA; Dabkowski PL; McKenzie IF Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11391-5. PubMed ID: 7504304 [TBL] [Abstract][Full Text] [Related]
43. A novel beta-galactosidase gene isolated from the bacterium Xanthomonas manihotis exhibits strong homology to several eukaryotic beta-galactosidases. Taron CH; Benner JS; Hornstra LJ; Guthrie EP Glycobiology; 1995 Sep; 5(6):603-10. PubMed ID: 8563148 [TBL] [Abstract][Full Text] [Related]
44. Developmental regulation of alternative exon usage in the house fly Vssc1 sodium channel gene. Lee SH; Ingles PJ; Knipple DC; Soderlund DM Invert Neurosci; 2002 Apr; 4(3):125-33. PubMed ID: 12488972 [TBL] [Abstract][Full Text] [Related]
45. Asn215Ser, Ala143Thr, and Arg112Cys variants in α-galactosidase A protein confer stability loss in Fabry's disease. Sudhan M; Janakiraman V; Patil R; Oyouni AAA; Hasan Mufti A; Ahmed SSSJ J Biomol Struct Dyn; 2023 Nov; 41(19):9840-9849. PubMed ID: 36420638 [No Abstract] [Full Text] [Related]
47. Identification of dual active sites in Cheong CSY; Khan SU; Ahmed N; Narayanan K J Biomol Struct Dyn; 2023 Jul; 41(11):5261-5276. PubMed ID: 35694994 [TBL] [Abstract][Full Text] [Related]
48. Rational design of cell active C2-modified DGJ analogues for the inhibition of human α-galactosidase A (GALA). Ashmus RA; Wang Y; González-Cuesta M; King DT; Tiet B; Gilormini PA; García Fernández JM; Ortiz Mellet C; Britton R; Vocadlo DJ Org Biomol Chem; 2021 Sep; 19(37):8057-8062. PubMed ID: 34494637 [TBL] [Abstract][Full Text] [Related]
49. Gala theory: Darwin reinforces regulation. Harris J; Wakeford T Trends Ecol Evol; 1996 Aug; 11(8):315-6. PubMed ID: 21237860 [No Abstract] [Full Text] [Related]
50. Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma. Nakano S; Morizane Y; Makisaka N; Suzuki T; Togawa T; Tsukimura T; Kawashima I; Sakuraba H; Shibasaki F PLoS One; 2013; 8(11):e78588. PubMed ID: 24236025 [TBL] [Abstract][Full Text] [Related]
51. Pharmacological chaperone therapy for Fabry disease. Ishii S Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(1):18-30. PubMed ID: 22241068 [TBL] [Abstract][Full Text] [Related]
52. Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T). Ebrahim HY; Baker RJ; Mehta AB; Hughes DA J Inherit Metab Dis; 2012 Mar; 35(2):325-34. PubMed ID: 21972175 [TBL] [Abstract][Full Text] [Related]
53. Naked plasmid DNA-based alpha-galactosidase A gene transfer partially reduces systemic accumulation of globotriaosylceramide in Fabry mice. Nakamura G; Maruyama H; Ishii S; Shimotori M; Kameda S; Kono T; Miyazaki J; Kulkarni AB; Gejyo F Mol Biotechnol; 2008 Feb; 38(2):109-19. PubMed ID: 18219591 [TBL] [Abstract][Full Text] [Related]
54. Corrective effect on Fabry mice of yeast recombinant human alpha-galactosidase with N-linked sugar chains suitable for lysosomal delivery. Sakuraba H; Chiba Y; Kotani M; Kawashima I; Ohsawa M; Tajima Y; Takaoka Y; Jigami Y; Takahashi H; Hirai Y; Shimada T; Hashimoto Y; Ishii K; Kobayashi T; Watabe K; Fukushige T; Kanzaki T J Hum Genet; 2006; 51(4):341-352. PubMed ID: 16532254 [TBL] [Abstract][Full Text] [Related]
55. Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice. Sakuraba H; Murata-Ohsawa M; Kawashima I; Tajima Y; Kotani M; Ohshima T; Chiba Y; Takashiba M; Jigami Y; Fukushige T; Kanzaki T; Itoh K J Hum Genet; 2006; 51(3):180-188. PubMed ID: 16372133 [TBL] [Abstract][Full Text] [Related]
56. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Ishii S; Nakao S; Minamikawa-Tachino R; Desnick RJ; Fan JQ Am J Hum Genet; 2002 Apr; 70(4):994-1002. PubMed ID: 11828341 [TBL] [Abstract][Full Text] [Related]